학술논문
PSY57 - Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus: A Cost-Effectiveness Analysis in Canada
Document Type
Abstract
Author
Source
In Value in Health May 2018 21 Supplement 1:S254-S255
Subject
Language
ISSN
1098-3015